| Literature DB >> 17671842 |
N D Wilson1, L J N Ross, J Close, R Mott, T J Crow, E V Volpi.
Abstract
In order to investigate the replication timing properties of PCDH11X and PCDH11Y, a pair of protocadherin genes located in the hominid-specific non-pseudoautosomal homologous region Xq21.3/Yp11.2, we conducted a FISH-based comparative study in different human and non-human primate (Gorilla gorilla) cell types. The replication profiles of three genes from different regions of chromosome X (ZFX, XIST and ATRX) were used as terms of reference. Particular emphasis was given to the evaluation of allelic replication asynchrony in relation to the inactivation status of each gene. The human cell types analysed include neuronal cells and ICF syndrome cells, considered to be a model system for the study of X inactivation. PCDH11 appeared to be generally characterized by replication asynchrony in both male and female cells, and no significant differences were observed between human and gorilla, in which this gene lacks X-Y homologous status. However, in differentiated human neuroblastoma and cerebral cortical cells PCDH11X replication profile showed a significant shift towards allelic synchrony. Our data are relevant to the complex relationship between X-inactivation, as a chromosome-wide phenomenon, and asynchrony of replication and expression status of single genes on chromosome X.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17671842 PMCID: PMC2779385 DOI: 10.1007/s10577-007-1153-y
Source DB: PubMed Journal: Chromosome Res ISSN: 0967-3849 Impact factor: 5.239
Figure 1Fluorescence in situ hybridization (FISH) allows visualization of replicated and unreplicated DNA fragments in the cell nuclear context. Examples of interphase nuclei showing in red: (A) a single-single (SS) hybridization pattern (both DNA segments have not replicated yet); (B) a double-double (DD) hybridization pattern (both DNA segments have already replicated); (C) and (D) single-double (SD) hybridization patterns (one fragment has replicated, but its homologue has not replicated yet). In A, B and D the nuclei are counterstained with Dapi (blue). In C hybridization was performed on BrdU pulse-labelled cells. The anti-BrdU antibody (green) identifies nuclei in S phase. (Scale bar = 10 µm.).
Summary of the ‘dot-counting’ replication timing assay carried out on five different genes (PCDH11, ATRX, XIST, ZFX and autosomal control probe) in different human and gorilla cell types
| SS | DD | SD | SD% | N | Singlets | Doublets | |
|---|---|---|---|---|---|---|---|
| PCDH | |||||||
| ♀ blood | 48 | 16 | 37 | 36% | 101 | 66% | 34% |
| ♀ line 1 | 58 | 11 | 40 | 37% | 109 | 72% | 28% |
| ♀ line 2 | 40 | 25 | 39 | 37% | 104 | 57% | 45% |
| ♀ line ICF | 45 | 16 | 39 | 39% | 100 | 65% | 35% |
| ♀ Gorilla | 41 | 23 | 38 | 37% | 102 | 59% | 41% |
| ♀ neurobl. | 40 | 26 | 40 | 38% | 106 | 57% | 43% |
| ♀ neurobl.dif. | 93 | 21 | 44 | 28% | 158 | 73% | 27% |
| ♀ cortical | 61 | 11 | 30 | 29% | 102 | 75% | 25% |
| ♂ blood | 66 | 19 | 36 | 30% | 121 | 69% | 31% |
| ♂ line | 51 | 10 | 43 | 41% | 104 | 70% | 30% |
| ATRX | |||||||
| ♀ blood | 50 | 11 | 45 | 42% | 106 | 68% | 32% |
| ♀ line 1 | 62 | 20 | 48 | 37% | 130 | 66% | 34% |
| ♀ line 2 | 52 | 19 | 38 | 35% | 109 | 65% | 35% |
| ♀ line ICF | 51 | 15 | 35 | 35% | 101 | 68% | 32% |
| ♀ Gorilla | 49 | 14 | 39 | 38% | 102 | 67% | 33% |
| ♀ neurobl. | 62 | 12 | 46 | 38% | 120 | 71% | 29% |
| ♀ neurobl.dif. | 48 | 17 | 44 | 40% | 109 | 64% | 36% |
| XIST | |||||||
| ♀ blood | 67 | 8 | 34 | 31% | 109 | 77% | 23% |
| ♀ line 1 | 49 | 13 | 41 | 40% | 103 | 67% | 33% |
| ♀ line 2 | 61 | 14 | 34 | 31% | 109 | 72% | 28% |
| ♀ Gorilla | 53 | 10 | 43 | 40% | 106 | 70% | 30% |
| ♀ neurobl. | 66 | 20 | 39 | 31% | 125 | 68% | 32% |
| ♀ neurobl.dif. | 63 | 15 | 49 | 38% | 127 | 69% | 31% |
| ZFX | |||||||
| ♀ blood | 55 | 19 | 37 | 33% | 111 | 66% | 34% |
| ♀ line 1 | 56 | 21 | 35 | 31% | 112 | 66% | 34% |
| ♀ line 2 | 61 | 13 | 40 | 35% | 114 | 71% | 29% |
| ♀ Gorilla | 48 | 21 | 36 | 34% | 105 | 63% | 37% |
| ♀ neurobl. | 66 | 21 | 34 | 28% | 121 | 69% | 31% |
| ♀ neurobl.dif. | 77 | 13 | 30 | 25% | 120 | 77% | 23% |
| Autosom. | |||||||
| ♀ blood | 84 | 6 | 25 | 22% | 115 | 84% | 16% |
| ♀ neurobl.dif. | 77 | 7 | 33 | 28% | 117 | 80% | 20% |
| ♂ blood | 86 | 2 | 28 | 24% | 116 | 86% | 14% |
| BrdU-Lab. | |||||||
| PCDH | 47 | 8 | 54 | 50% | 109 | n.a. | n.a. |
| ATRX | 40 | 12 | 51 | 49% | 103 | n.a. | n.a. |
| Xist | 41 | 18 | 47 | 44% | 106 | n.a. | n.a. |
| ZFX | 73 | 36 | 100 | 48% | 209 | n.a. | n.a. |
| autosom. | 44 | 19 | 48 | 43% | 111 | n.a. | n.a. |
‘SS’ is the number of single-single hybridization patterns observed in each experiment, ‘DD’ is the number of double-double hybridization patterns observed in each experiment and ‘D’ is the number of single-double hybridization patterns observed in each experiment (also shown as a percentage), while ‘N’ is the total number of nuclei analysed for each experiment. ‘BrdU-labelled’ indicates the observations carried out on BrdU-positive nuclei. Percentages of total number of single signals (‘Singlets’) and double signals (‘Doublets’) are also included.
Figure 2Graphic representation of the test carried out on the hypothesis of no differences in replication profile between all four X-linked genes (ATRX, PCDH11X, XIST and ZFX) in female human blood cells, female human B cells (line 1 and line 2), female gorilla B cells and female human differentiated neuroblastoma cells. Only differentiated neuroblastoma cells showed significant differences between the genes.
Figure 3Expression of X-linked genes in cell lines. Samples are as follows: 1: DO208915 (female B-cell line), 2: GM08714 (female ICF B-cell line), 3: SHYSY5Y (female neuroblastoma cell line), 4: differentiated SHYSY5Y, 5: female brain control, 6: negative control. Molecular weight marker is HyperLadderV (bioline). Expression of control genes can be observed in all samples and all products are appropriate size. Expression of PCDH11 is observed only in female brain control sample.
Results of quantitative RT-PCR on cell line samples relative to female brain control; the expression level is negligible in the cell lines tested
| Sample | Relative expression |
|---|---|
| Neuroblastoma | |
| Differentiated neuroblastoma | 0.00001776 |
| Undifferentiated female brain | 0.00001874 |
| 1.00000000 |